Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 16,189

Document Document Title
WO/2021/232169A1
The present disclosure provides a dual-drag-containing nanoparticle, in which a first antiviral drag, such as remdesivir and a second antiviral drag are co-encapsulated and co-delivered by the nanoparticle, said nanoparticle comprising a...  
WO/2021/224018A1
The present invention describes linear compounds comprising hydrophobic tails, multiple ethoxylates and a C4-C6 end cap. The invention also relates to compositions comprising these compounds, in particular watery compositions, across a w...  
WO/2021/220800A1
As a catalyst for realizing high palladium dispersity and a stable, electron-rich palladium site, there is provided a catalyst in which particles of an intermetallic compound of palladium and zirconium are supported on zirconium carbide ...  
WO/2021/213627A1
The present invention relates to novel fragrance compounds of general formula (I) which exhibit a Sandalwood-like fragrance and which are derivable from campholenic aldehyde derivates according to general formula (II). Furthermore, the p...  
WO/2021/204193A1
The present invention belongs to the field of medicaments or nutraceutical products, and specifically relates to a compound represented by the following general formula (I), or an enantiomer, diastereomer, salt, ester, prodrug, solvate, ...  
WO/2021/204531A1
1-methoxy-2-propanol and 2-methoxy-1-propanol are recovered from an aqueous effluent stream by liquid-liquid-extraction, followed by extractive distillation, distillation of methoxypropanols from the extraction solvent and distillative s...  
WO/2021/204789A2
The present invention relates to a process for recycling polyacetal having from 8 to 100 000 carbon atoms for obtaining a produced polyoxymethylene dialkyl ether of formula R-(OCH2)n-OR', in which R and R' independently represent a methy...  
WO/2021/119397A9
The present invention relates to metal salts of 2-[3-[(3R)-3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2, 2-diphenylethyl)amino]butoxy]phenyl]acetic acid which exhibit improved physical properties and stability. The invention also rel...  
WO/2021/202343A1
Gas separation membranes are provided and more particularly, a series of addition-type and ROMP type polynorbornenes with substituents derived from Mizoroki-Heck reactions are provided and have particular utility as gas separation membra...  
WO/2021/202986A1
The disclosure provides therapeutic compounds, compositions (e.g., therapeutic agents or medicaments) and methods for preventing or treating mitochondrial disease such as Friedreich's ataxia in a mammalian subject, reducing risk factors,...  
WO/2021/199310A1
The present invention is a method for producing an aromatic compound by cross-coupling reaction between a nucleophile and an electrophile, the method including a step for using Pd(OAc)2(PCy3)2 as a catalyst and causing the nucleophile an...  
WO/2021/198806A1
Method for lowering aldehyde content in a mixture comprising (i) diethylene glycol (DEG) and/or triethylene glycol (TEG) and (ii) aldehyde are disclosed. An ion exchange resin is soaked in monoethylene glycol. The mixture comprising 5 to...  
WO/2021/199003A1
The present invention is directed to methods of treating or preventing inflammation caused by a coronavirus infection with oxidized lipid compounds (e.g., VB-201). The present invention also directed to methods of treating or preventing ...  
WO/2021/191113A1
The invention relates to a process for producing para-eugenol and/or ortho-eugenol comprising a step (i) of deallylation of at least one compound of formula (I): in which R1 and R2 are different, and selected from the group consisting of...  
WO/2021/193952A1
This compound has a chain structure in which an aromatic ring group, an ether oxygen, a methylene group, an aromatic ring group, a methylene group, an ether oxygen, and an aromatic ring group are bonded in the listed order. To a carbon o...  
WO/2021/187075A1
This polycyclic aromatic hydrocarbon compound is represented in formula (1). (In the formula, Z is a polycyclic aromatic hydrocarbon having three bonded benzene rings, L1 is an alkylene group with 1-15 carbon atoms, R1 is a hydrocarbon g...  
WO/2021/186271A1
Described herein is a method to synthesize a perfluorinated allyl ether compound of formula (I) or a perfluorinated allyl amine compound of formula (II) Where Rf 1 and Rf 2 are (i) independently selected from a perfluorinated alkyl group...  
WO/2021/182438A1
The purpose of the present invention is to provide a composition containing a borate compound which is useful as a cocatalyst for the solution polymerization of olefin or diene and is soluble in a hydrocarbon solvent. According to the ...  
WO/2021/177287A1
The present invention addresses the problem of providing a catalyst which exhibits high reusability and is capable of reducing the amount of residual metals in a reaction liquid in a process wherein an optically active reduction product ...  
WO/2021/177290A1
A method for producing a mono-cross-coupled aromatic compound (3-1), said method comprising: preparation of an aromatic compound (1) that has at least two leaving groups; preparation of a compound (2) that is capable of undergoing a cros...  
WO/2021/177000A1
A method for producing a fluorine-containing olefin by causing a reaction between a second olefin and a first olefin represented by formula (1) in the presence of a ruthenium compound represented by formula (X).  
WO/2021/170864A1
The present invention is directed to a process for the manufacture of 1,1,4,4- tetramethoxy-2-butene from 2,5-dimethoxy-2,5-dihydrofuran with methanol in the presence of an acidic ion exchanger as catalyst, whereby the molar ratio of 2,5...  
WO/2021/160139A1
A 9,10-dihydrophenanthrene compound and use thereof in the treatment of liver injury. Specifically, a compound of formula (I) or a compound of formula (II) is provided, which exhibits anti-inflammatory and antioxidant activities in liver...  
WO/2021/161807A1
The present invention provides an efficient production method for obtaining reduced coenzyme Q10 crystals of Form II that is a stable crystalline form. The production method of the present invention comprises a step for adding a Form I...  
WO/2021/160920A1
Dendrimer-based nanostructures for the diagnosis of allergies to beta-lactam antibiotics and applications. The structure has the formula B-D-L-H-L-D-B, where: H is a hydrophilic polymer (PEG), L is a linker (maleimide), D is a dendrimer ...  
WO/2021/157563A1
A fluorine-containing ether compound that is characterized by being represented by the following formula (1). Formula (1): R1-(O(CH2)a)b-[A]-[B]-O-CH2-R2-CH2-R3 (In formula (1), R1 is an alkyl group that may have a substituent group, o...  
WO/2021/151871A1
The invention relates to a method for producing oxymethylene ether of the general formula CH3O-(CH2O)m-CH3 in a liquid phase process, wherein 1 ≤ m ≤ 10. In a catalytic reaction, molecular oxygen or an oxygen-containing oxidizing age...  
WO/2021/149801A1
This fullerene derivative has a structure represented by formula (1) or formula (2) (wherein Ar represents a substituted or unsubstituted aromatic ring, * represents a carbon atom at a linkage point with respect to a fullerene core, X re...  
WO/2021/144678A1
A compound having structural formula (II): where R2 is H, CH3, CF3, CH2CF2CF2H, or CH2CF2CF2CF2CF2H; where R2f is a perfluoroalkyl group having 1-4 carbon atoms, optionally comprising either or both of a catenated nitrogen heteroatom and...  
WO/2021/137137A1
A chlorinated fluoroaromatic compound having structural formula (I): where G is an oxygen or sulfur atom; each R1 is, independently, a fluoroalkenyl group having 2 to 10 carbon atoms and optionally comprises one or more catenated heteroa...  
WO/2021/131961A1
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-OCH2CH(OH)CH2O-CH2-R3-CH2-R4-R5 (In the formula, R3 is a perfluoropolyether chain; R2 and R4 are each a divalent linking group having...  
WO/2021/131993A1
A fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-OCH2CH(OH)CH2O-CH2-R3-CH2-R4-R5 (In the formula, R3 is a perfluoropolyether chain; R2 and R4 are divalent linking groups each having a polar grou...  
WO/2021/127743A1
The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.  
WO/2021/129022A1
Disclosed are a biomass-based long-chain alcohol ether oxygen-containing additive, a preparation method therefor and an application thereof. The raw material of the additive is agricultural and forestry waste, and the general chemical fo...  
WO/2021/124158A1
The present invention is directed to an efficient process for preparing benzoxazole derivatives comprising the step of reacting a 4-Amino-3-hydroxybenzoic acid compound of Formula III with a 3,5-Dichlorophenyl ortho ester compound of For...  
WO/2021/119716A1
A process for continuous preparation of halogenated alkoxyethane of general formula XC1HC-CF2OR, where X is –Cl or –f and OR is C1-4 alkoxy, the process comprising a step of introducing in a flow reactor reaction components comprisin...  
WO/2021/119826A1
In aspects, a cannabis extract enriched in polyphenolic compounds is provided herein. Also provided herein is a method for enriching a composition with polyphenolic compounds as well as compositions made by the method. Various cosmetic a...  
WO/2021/125347A1
The present invention provides a crosslinking agent which is capable of improving the high-temperature steam resistance of a crosslinked fluoroelastomer; and a crosslinked fluoroelastomer which has improved high-temperature steam resista...  
WO/2021/119717A1
A process for continuous preparation of halogenated alkoxyethane of general formula XClHC-CF2OR, where X is –Cl or –F and OR is C1-4 alkoxy, the process comprising a step of introducing in a flow reactor reaction components comprisin...  
WO/2021/123162A1
The present disclosure relates to a cocrystal of pterostilbene and a coformer capable to form hydrogen bond interactions, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The present discl...  
WO/2021/116980A1
Systems and methods for producing MTBE are disclosed. A C4 feed stream containing isobutylene and other C4 hydrocarbons is fed into a reactor unit for producing MTBE. The effluent of the reactor unit comprising MTBE is further processed ...  
WO/2021/113958A1
This disclosure relates generally to cannabinoid derivatives, pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives.  
WO/2021/110680A1
The present invention relates to compounds of formula (I) as properfume compounds. In particular, the present invention relates to a method to release a compound being a carbonyl of formula (II), a formate ester of formula (III) and/or a...  
WO/2021/112661A1
The present invention relates to a process for obtaining polymer nanoparticles stabilised with a non-ionic polymer surfactant functionalised with a ligand, for receptor-mediated drug delivery. The distinctive feature of the invention is ...  
WO/2021/107646A1
The present invention provides a method for efficiently and economically producing Maxacalcitol, and an intermediate used therefor.  
WO/2021/106535A1
Provided are an active-ray-sensitive or radiation-sensitive resin composition, and a pattern formation method and electronic device manufacturing method using said active-ray-sensitive or radiation-sensitive resin composition. The active...  
WO/2021/063870A9
The present invention relates to methods for producing at least one vinyl ether compound of formula (I) and to a vinyl ether compound of formula (I) preferably obtainable by the methods according to the invention. Furthermore, the presen...  
WO/2021/105322A1
The present patent application relates to an aqueous composition comprising: a) at least one compound having general formula (I) and at least one compound having general formula (II), and/or at least one compound having general formula (...  
WO/2021/106979A1
A liquid crystal aligning agent which contains the components (A) and (B) described below. (A): A polyimide which is obtained by imidizing a polyimide precursor that is obtained by a reaction between a tetracarboxylic acid component an...  
WO/2021/108254A1
The present disclosure provides methods for preparing MCL1 inhibitors or a salt thereof and related key intermediates.  

Matches 301 - 350 out of 16,189